<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Herein we report a polymerase chain reaction (PCR)-free electrochemiluminescence (ECL) approach that uses ECL nanoprobes for the determination of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells with high sensitivity </plain></SENT>
<SENT sid="1" pm="."><plain>The ECL nanoprobe consists of <z:chebi fb="0" ids="50825">gold nanoparticles</z:chebi> (<z:chebi fb="0" ids="50825">AuNPs</z:chebi>), linker DNA, and <z:chebi fb="3" ids="9754">tris</z:chebi>(<z:chebi fb="0" ids="30351">2,2'-bipyridyl</z:chebi>)<z:chebi fb="6" ids="30682">ruthenium</z:chebi> (TBR)-labeled signal DNA </plain></SENT>
<SENT sid="2" pm="."><plain>The linker DNA and signal DNA were modified on the surface of the <z:chebi fb="0" ids="50825">AuNPs</z:chebi> through Au-S bonds </plain></SENT>
<SENT sid="3" pm="."><plain>The linker DNA can partly hybridize with the aptamers of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells loaded onto the magnetic beads (MB1) to construct the magnetic biocomplexes </plain></SENT>
<SENT sid="4" pm="."><plain>In the presence of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, the aptamers conjugated with the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells with higher affinity </plain></SENT>
<SENT sid="5" pm="."><plain>The ECL nanoprobe was released from the biocomplexes and subsequently hybridized with the capture DNA loaded onto another magnetic bead (MB2) to form the magnetic nanocomposite </plain></SENT>
<SENT sid="6" pm="."><plain>The nanocomposites can be easily separated and firmly attached to an electrode on account of their excellent magnetic properties </plain></SENT>
<SENT sid="7" pm="."><plain>The ECL intensity of the TBR loaded onto the nanocomposites directly reflected the amount of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells </plain></SENT>
<SENT sid="8" pm="."><plain>By using cell lines of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (Ramos cells) as a model, the ECL response was proportional to the cell concentration in the range from 5 to 100 cells ml(-1); a limit of detection as low as 5 cells ml(-1) of Ramos cells could be achieved </plain></SENT>
<SENT sid="9" pm="."><plain>The proposed method described here is ideal for the diagnosis of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> due to its high sensitivity, simplicity, and low cost </plain></SENT>
</text></document>